CD274 and cancer: Therefore, a better understanding of the mechanisms of action of anti-PD-L1 (or anti-PD-1) mAb therapy and the impact of this therapy on each component of the tumor immune microenvironment will help improve the precision of cancer immunotherapeutics in the future.